Innovation: Focused discovery, development and commercialization of better drugs for children and adolescents with cancer
Targeted Cancer(s): All types of pediatric cancer
Leadership: Ricardo Garcia, Co-founder and CEO; Cesare Spadoni, Ph.D., MBA, Co-founder and COO; Marc Goldberg, J.D., MBA, Co-founder; Marco Munoz, Co-founder (Click here to view our team)
Stage of Business: $3 million seed
Oncoheroes Biosciences is building a multi-asset pediatric drug portfolio by, over the short-term, in-licensing clinical or near-clinical stage assets and, over the long-term, identifying novel targets in its own labs for existing compounds and creating new intellectual property. The company leverages ecosystem partners to support asset selection, development and clinical trials. Its business model is the commercialization of pediatric oncology drugs through optimal pathways and out-licensing products with adult use.